Home > Healthcare > Biotechnology > Bioservices > proteomics market
Get a free sample of Proteomics Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Proteomics Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Proteomics Market size was valued at USD 46.68 billion in 2022 and is expected to register around 10% CAGR between 2023 and 2032. The increasing research activity being conducted in the field of personalized medicine and in the pharmaceutical industry for drug discovery and development form the primary growth factors of the market expansion. Additionally, the increasing R&D expenditure by pharmaceutical and biotechnology companies, increasing government funding, and the technological advancement among analytical tools is propelling the market growth.
On the other hand, the high cost of the instruments may hinder the growth of the market to a certain extent. Proteomics involves the use of equipment such as X-ray crystallography, mass spectrometers, and high-throughput fields to conduct protein structure, expression, and crystallization studies. These processes lead to increase in the cost per sample testing. The rising cost of instruments may also impede the adoption in developing countries, thus limiting the growth of the market. Also, the drawbacks of data management and storage during bioinformatics analysis limits their adoption, inhibiting the market demand
Europe proteomics market is anticipated to cross USD 42 billion by 2032, as a result of the rise in government funding for clinical life sciences research projects.
Consumables component segment will cross USD 83.5 billion by 2032, due to the application scope of kits, strips, and other consumables in biological sample examination.
The market size for proteomics crossed USD 46.5 billion in 2022 and is poised to depict more than 10% CAGR through 2023-2032, given the escalating investment in cancer proteogenomics.
Seer, Inc, Biognosys AG, Creative ProteomicsAgilent Technologies, Inc, Promega Corporation, Thermo Fisher Scientific, Bruker, Bio-Rad Laboratories, Quantum-Si, Inc, PREOMICS GMBH, and Olink are some of the key companies included in the market.